Extension of Rights Issue Closing Date
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Hydration Pharmaceuticals Company Limited has announced an extension of the closing date for its non-renounceable rights issue. The new closing date is now set for a later date, providing eligible shareholders additional time to submit their applications. All other terms and conditions of the rights issue remain unchanged. This announcement was authorized for release by the Board of Hydralyte USA.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Hydration Pharmaceuticals Company Limited on 6ix
Earlier from Hydration Pharmaceuticals
- Update - Proposed issue of securities - HPC
- Investor Presentation
- Change of Director's Interest Notice
- Notification of cessation of securities - HPC
- Rights Offer - Despatch of Prospectus
Follow Hydration Pharmaceuticals into a list and get an email when it puts out news.
Follow Hydration Pharmaceuticals